| Literature DB >> 26958600 |
Anugerah Dany Priyanto1, Robert J Doerksen2, Chi-I Chang3, Wang-Chou Sung4, Simon Bambang Widjanarko5, Joni Kusnadi5, Ya-Chi Lin3, Ting-Chin Wang3, Jue-Liang Hsu6.
Abstract
VY-7 has been demonstrated as a potent ACE inhibitory peptide in the previous study [1]. In this article, we provide accompanying data about the identification of bitter melon seed proteins (BMSPs), and quantitative analysis and optimized production of VY-7 in BMSPs hydrolysate.Entities:
Year: 2015 PMID: 26958600 PMCID: PMC4773410 DOI: 10.1016/j.dib.2015.09.038
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1ACE inhibitory activities of the BMSP hydrolysates digested using different proteolytic enzymes. The hydrolysates derived from different enzymes were ultrafiltrated using 3 kDa MWCO ultrafiltration membranes and the resulting filtrates were lyophilized and subjected individually to ACE inhibitory assay.
Fig. 2LC–MS/MS chromatograms. (A) Full chromatogram of the BMSP thermolysin digest; (B) MRM of VY-7 in the crude thermolysin digest of BMSPs; and (C) MRM chromatogram of synthetic VY-7 spiked in the BMSP thermolysin digest.
Effects of enzyme to substrate ratio (w/w), hydrolysis time (h), and temperature (°C) on peptide amount (μg/mg).
| 1:50 | 12 | 60 | 10.20±0.84 |
| 1:100 | 14.89±0.88 | ||
| 1:200 | 10.65±0.85 | ||
| 1:400 | 4.21±0.44 | ||
| 1:800 | 2.78±0.05 | ||
| 1:100 | 1 | 2.05±0.25 | |
| 3 | 3.96±0.79 | ||
| 6 | 7.77±0.48 | ||
| 9 | 10.34±0.68 | ||
| 15 | 2.48±0.26 | ||
| 12 | 40 | 4.42±0.23 | |
| 50 | 8.05±0.27 | ||
| 70 | 1.49±0.05 |
Fig. 3HPLC chromatograms of the BMSP thermolysin hydrolysate digested using condition (A) before; and (B) after optimization. The target peptide VY-7 is located between the two dotted lines.
| Subject area | Chemistry, Biology |
|---|---|
| More specific subject area | Angiotensin-I converting enzyme inhibitory peptides |
| Type of data | Tables of identified sequences and peptide yield enhancement; text description of the data; and figures of ACE inhibitory activities, LC–MS/MS and HPLC for BMSP hydrolysates |
| How data was acquired | Mass spectrometry, database search, ACE inhibitory assay, SDS-PAGE |
| Data format | Raw, filtered, and analyzed |
| Experimental factors | These are described in the text description of the data |
| Experimental features | These are described in the text description of the data |
| Data source location | Pingtung, Taiwan |
| Data accessibility | Data is supplied in this article |